• to reduced the potential risk of severe cardiovascular (coronary heart and blood vessel) difficulties in Older people with kind two diabetes and cardiovascular diseaseNovo Nordisk A/S can be a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] with creation amenities in 9 international locations and affiliate marketers o